YDES YD Bio (NASDAQ:YDES) is an integrated biotechnology company that combines diagnostics, precision medicine, and regenerative ophthalmology under a single commercial and development strategy. The ...

THE ARTICLES ON THESE PAGES ARE PRODUCED BY BUSINESS REPORTER, WHICH TAKES SOLE RESPONSIBILITY FOR THE CONTENTS ...

NEW YORK CITY, NEW YORK / ACCESS Newswire / January 10, 2026 / New to The Street, the nationally syndicated business media platform, announced today that its 30-minute biographical feature on IMG ...

Explore the future of sustainable composites in architecture, from bio-based and recycled materials to hybrid solutions.

The Bio-Hermes-002 study collects data reflecting the performance of each biomarker in the study, or combination of biomarkers, to assess, diagnose or predict the presence of a variety of pathologies ...

New immune profiling data confirms disease-modifying mechanism, reinforces earlier signals of fibrosis resolution, lung ...

What is the future of downtown Dallas? Even for a place that is persistently described as “at a crossroads” and “in crisis,” ...

David Calone has been a mainstay in Long Island’s tech, venture capital and civic life for more than 15 years now. He is head ...

Adams announced in May that he was dying of metastatic prostate cancer. Thousands of newspapers carried his strip satirizing ...

Eco-friendly footwear will not become mainstream until consumer demand is widespread, but here are some companies making the ...

Scott Adams net worth explained: how the Dilbert creator earned an estimated $20 million through syndication, licensing, ...